Wilshire Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for WILSHIRE PHARMS INC, and what generic and branded alternatives to WILSHIRE PHARMS INC drugs are available?
WILSHIRE PHARMS INC has eleven approved drugs.
Summary for Wilshire Pharms Inc
| US Patents: | 0 |
| Tradenames: | 11 |
| Ingredients: | 11 |
| NDAs: | 11 |
Drugs and US Patents for Wilshire Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wilshire Pharms Inc | PERPHENAZINE | perphenazine | TABLET;ORAL | 205973-001 | Dec 17, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Wilshire Pharms Inc | DEOXYCHOLIC ACID | deoxycholic acid | SOLUTION;SUBCUTANEOUS | 212296-001 | Apr 2, 2021 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Wilshire Pharms Inc | PERPHENAZINE | perphenazine | TABLET;ORAL | 205973-003 | Dec 17, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Wilshire Pharms Inc | PERPHENAZINE | perphenazine | TABLET;ORAL | 205973-004 | Dec 17, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
